SunWay Biotech Co., LTD. (TPEX:1271)

Market Cap	3.67B -15.7%
Revenue (ttm)	993.30M +2.4%
Net Income	101.50M -14.4%
EPS	1.68 -14.3%
Shares Out	60.39M
PE Ratio	36.13
Forward PE	n/a
Dividend	1.00 (1.68%)
Ex-Dividend Date	Jul 30, 2026

Volume	104,442
Open	59.30
Previous Close	59.40
Day's Range	57.00 - 59.70
52-Week Range	51.00 - 90.80
Beta	-0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About SunWay Biotech Co., LTD.

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company offers red yeast rice and lactic acid bacteria products, as well as other health supplements; and wholesale and manufacturing of pharmaceutical products. The company also researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1271

Financial Performance

In 2025, SunWay Biotech Co., LTD.'s revenue was 993.30 million, an increase of 2.38% compared to the previous year's 970.18 million. Earnings were 101.50 million, a decrease of -14.40%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 29, 2026

Data Sources Report a data error